KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease is a research paper published in Cell Metabolism (2021). On theSindex it has a DataRank of 0. It has been cited 285 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: K01 DK099473
Juvenile Diabetes Research Foundation International
Grant: 3-PDF-2014-110-A-N
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK072381
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK099473-01
NIDDK NIH HHS
Grant: R37 DK039773
NIDDK NIH HHS
Grant: R01 DK121101
NIDDK NIH HHS
Grant: R01 DK072381
Philippe Foundation
Grant: TW-37
Uehara Memorial Foundation
American Society of Nephrology
American Heart Association
Japan Society for the Promotion of Science
Royal Australasian College of Physicians
Fondation pour la Recherche Médicale
National Institutes of Health
Tizona Therapeutics
Boehringer Ingelheim
MeSH Terms
Keywords
Additional file 1 of Exploration of a panel of urine biomarkers of kidney disease in two paediatric cohorts with Type 1 diabetes mellitus of differing duration
Additional file 1 of Exploration of a panel of urine biomarkers of kidney disease in two paediatric cohorts with Type 1 diabetes mellitus of differing duration
Additional file 1 of SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Additional file 1 of SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Additional file 2 of SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Additional file 2 of SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease